• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Involvement of thrombin/thrombin receptor signaling in the development of vascular remodeling

Research Project

Project/Area Number 10470167
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKagoshima University

Principal Investigator

MARUYAMA Ikuro  Kagoshima University, Faculty of Medicine, Professor, 医学部, 教授 (20082282)

Co-Investigator(Kenkyū-buntansha) KITAJIMA Isao  Kagoshima University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (50214797)
Project Period (FY) 1998 – 1999
KeywordsThrombin / Thrombin receptor / MAP kinase / atherosclerosis
Research Abstract

We have investigated in the signal transduction from thrombin receptor, PAR-1 and its role in the development in atherosclerosis/vascular remodeling and thrombosis.
We identified as follows:
1. The activation of PAR-1 by thrombin causes the expression of cell adhesion molecules(CAM), inflammatory cytokines, tissue factor, and PAI-1. This may play some roles in the development in atherosclerosis/vascular remodeling and thrombosis.
2.Thrombin activates PAR-1, and causes the activation of NF-ィイD2κィエD2B through MAP kinase pathway, resulting the proliferation of vascular smooth muscle cells.
3. On the other hand, PAR-1 activation causes apoptosis through caspase cascade.
4.Furthermore, we showed the signaling from PAR-1 activates histone acetyltransferase(HAT) with CBP/p300 activation in the cultured vascular smooth muscle cells. This causes accumulation of acetylated proteins at lysine residue, named as hyper-nuclear acetylation(HNA).
5. We showed HNA in atherosclerotic plaque in human cororary artery.
Based on these data, we conclude the signaling from thrombin receptor activates NF-ィイD2κィエD2B and CBP/p300 through MAP kinase cascade. This may cause proliferation, activation, and/or apoptosis in vascular smooth muslce cells, and play some roles for the development in vascular remodeling/restenosis and atherosclerosis/thrombosis.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Maruyama I: "Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular"Thromb Haemost. 82. 718-721 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawahawa K, Maruyama I: "hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells"Biochem Biophys Res Commun. 266. 417-424 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeno N, Maruyama I: "Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis"J Rheumatol. 26. 2244-2248 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sarker KP, Maruyama I: "Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510"Thromb Haemost. 82. 1071-1077 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I, Maruyama I: "Phosphothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo"Antisense Nucleic Acid Drug Dev.. 9. 233-239 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shin H, Maruyama I: "Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblasts"Ann Rheum Dis.. 58. 55-60 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maruyama I: "Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular."Thromb Haemost. 82. 718-721 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawahara I, Maruyama I: "Hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells."Biochem Biophys Res Commun. 266. 417-424 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeno N, Takei S, Imanaka H, Takasaki I, Kitajima I, Maruyama I, Matsuo K, Miyata K: "Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis."J Rheumatol.. 26. 2244-2248 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sharker KP, Abeyama K, Nishi JI, Nakata M, Tokioka T, Nakajima T, Kitajima I, Maruyama I: "Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510"Thromb Haemost. 82. 1071-1077 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I, Unoki K, Maruyama I: "Phosphothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo."Antisense Nucleic Acid Drug Dev.. 9. 233-239 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shin H, Kitajima I, Nakajima T, Shao Q, Tokioka T, Takasaki I, Hanyu N, Kubo T, Maruyama I: "Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblast"Ann Rheum Dis. 58. 55-60 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi